par Van Den Neste, Eric;Martiat, Philippe 
;Mineur, Philippe;Delannoy, André;Doyen, C;Zenebergh, Andrée;Michaux, Jean Louis;Ferrant, Augustin
Référence Annals of hematology, 76, 1, page (19-23)
Publication Publié, 1998-01
;Mineur, Philippe;Delannoy, André;Doyen, C;Zenebergh, Andrée;Michaux, Jean Louis;Ferrant, AugustinRéférence Annals of hematology, 76, 1, page (19-23)
Publication Publié, 1998-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Van Den Neste, Eric; Martiat, Philippe; Mineur, Philippe; Delannoy, André; Doyen, C; Zenebergh, Andrée; Michaux, Jean Louis; Ferrant, Augustin |
| Informations sur la publication: | Annals of hematology, 76, 1, page (19-23) |
| Statut de publication: | Publié, 1998-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adolescent |
| Adult | |
| Aged | |
| Antineoplastic Agents -- therapeutic use | |
| Cladribine -- administration & dosage | |
| Cladribine -- adverse effects | |
| Cladribine -- therapeutic use | |
| Daunorubicin -- administration & dosage | |
| Daunorubicin -- adverse effects | |
| Female | |
| Humans | |
| Leukemia, Myeloid, Acute -- drug therapy | |
| Leukemia, Myeloid, Acute -- mortality | |
| Male | |
| Middle Aged | |
| Recurrence | |
| Survival Rate | |
| Treatment Outcome | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase II | |
| Journal Article | |
| Randomized Controlled Trial | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0939-5555 |
| info:pmid/9486920 |
